| The physics of radioembolization |
14 |
| A deep learning approach for F-18-FDG PET attenuation correction |
14 |
| Evaluation of zero-echo-time attenuation correction for integrated PET/MR brain imaging-comparison to head atlas and Ge-68-transmission-based attenuation correction |
10 |
| Quantitative SPECT: the time is now |
10 |
| Initial experience with a SiPM-based PET/CT scanner: influence of acquisition time on image quality |
10 |
| Feasibility study of a novel general purpose CZT-based digital SPECT camera: initial clinical results |
8 |
| Impact of a Bayesian penalized likelihood reconstruction algorithm on image quality in novel digital PET/CT: clinical implications for the assessment of lung tumors |
7 |
| Radiation dosimetry of [Ga-68]PSMA-11 in low-risk prostate cancer patients |
6 |
| Accuracy and reproducibility of simplified QSPECT dosimetry for personalized Lu-177-octreotate PRRT |
6 |
| Performance characteristics of silicon photomultiplier based 15-cm AFOV TOF PET/CT |
6 |
| Feasibility of simplifying renal dosimetry in Lu-177 peptide receptor radionuclide therapy |
6 |
| Comparison of radiobiological parameters for Y-90 radionuclide therapy (RNT) and external beam radiotherapy (EBRT) in vitro |
5 |
| Determination of gamma camera calibration factors for quantitation of therapeutic radioisotopes |
5 |
| Reproducibility of compartmental modelling of F-18-FDG PET/CT to evaluate lung inflammation |
5 |
| Feasibility and accuracy of single time point imaging for renal dosimetry following Lu-177-DOTATATE (Lutate') therapy |
5 |
| Impact of penalizing factor in a block-sequential regularized expectation maximization reconstruction algorithm for F-18-fluorocholine PET-CT regarding image quality and interpretation |
4 |
| Radiation precautions for inpatient and outpatient Lu-177-DOTATATE peptide receptor radionuclide therapy of neuroendocrine tumours |
4 |
| Algorithms for joint activity-attenuation estimation from positron emission tomography scatter |
4 |
| Deadtime effects in quantification of Lu-177 activity for radionuclide therapy |
4 |
| Implementation of cylindrical PET scanners with block detector geometry in STIR |
4 |
| Impact of different approaches to calculation of treatment activities on achieved doses in radioiodine therapy of benign thyroid diseases |
4 |
| Molecular imaging using the theranostic agent Hg-197(m): phantom measurements and Monte Carlo simulations |
3 |
| Accelerated SPECT image reconstruction with FBP and an image enhancement convolutional neural network |
3 |
| Feasibility of PET/CT system performance harmonisation for quantitative multicentre Zr-89 studies |
3 |
| Inter-comparison of quantitative imaging of lutetium-177 (Lu-177) in European hospitals |
3 |
| NEMA NU 2-2007 performance characteristics of GE Signa integrated PET/MR for different PET isotopes |
3 |
| Evaluation of a Bayesian penalized likelihood reconstruction algorithm for low-count clinical F-18-FDG PET/CT |
3 |
| System evaluation of automated production and inhalation of O-15-labeled gaseous radiopharmaceuticals for the rapid O-15-oxygen PET examinations |
3 |
| Performance evaluation of Cerenkov luminescence imaging: a comparison of Ga-68 with F-18 |
3 |
| Fast quantitative reconstruction with focusing collimators for liver SPECT |
3 |
| Towards standardization of absolute SPECT/CT quantification: a multi-center and multi-vendor phantom study |
3 |
| Performance evaluation of a novel brain-dedicated SPECT system |
3 |
| Quantitative implications of the updated EARL 2019 PET-CT performance standards |
2 |
| Quantitative performance of I-124 PET/MR of neck lesions in thyroid cancer patients using I-124 PET/CT as reference |
2 |
| Characterisation of the attenuation properties of 3D-printed tungsten for use in gamma camera collimation |
2 |
| Image quality and detectability in Siemens Biograph PET/MRI and PET/CT systems-a phantom study |
2 |
| Impact of PET reconstruction protocols on quantification of lesions that fulfil the PERCIST lesion inclusion criteria |
2 |
| Quantitative analysis of phantom studies of In-111 and Ga-68 imaging of neuroendocrine tumours |
2 |
| SMART (SiMulAtion and ReconsTruction) PET: an efficient PET simulation-reconstruction tool |
2 |
| Predictive power of the post-treatment scans after the initial or first two courses of [Lu-177]-DOTA-TATE |
2 |
| Image-based SPECT calibration based on the evaluation of the Fraction of Activity in the Field of View |
2 |
| Validation of gallbladder absorbed radiation dose reduction simulation: human dosimetry of [F-18]fluortriopride |
2 |
| Multi institutional quantitative phantom study of yttrium-90 PET in PET/MRI: the MR-QUEST study |
2 |
| A Nordic survey of CT doses in hybrid PET/CT and SPECT/CT examinations |
2 |
| Biodistribution, pharmacokinetics, and organ-level dosimetry for Re-188-AHDD-Lipiodol radioembolization based on quantitative post-treatment SPECT/CT scans |
2 |
| Reducing the number of CTs performed to monitor personalized dosimetry during peptide receptor radionuclide therapy (PRRT) |
2 |
| Real-time data-driven motion correction in PET |
2 |
| Validation of the physiological background correction method for the suppression of the spill-in effect near highly radioactive regions in positron emission tomography |
2 |
| Performance evaluation of a new high-sensitivity time-of-flight clinical PET/CT system |
1 |
| Quantitative measurement of Rn-219 radioactivity in exhaled breath from patients with bone metastasis of castration-resistant prostate cancer treated with (RaCl2)-Ra-223 |
1 |
